Back to search
Melanoma of Unknown Primary
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Melanoma of Unknown Primary trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Melanoma of Unknown Primary trials you may qualify forThis study will collect, annotate, and sequence biospecimens (blood, tissue, urine, saliva and surgery drainage) from patients across different cancer types to…
Studies have shown that tumors from the same patient may respond very differently to the same therapeutic agents. This study aims to investigate the genetic bas…
This phase II trial investigates how well biomarkers on PET/CT imaging drive early discontinuation of anti-PD-1 therapy in patients with stage IIIB-IV melanoma…
This randomized phase III trial studies ipilimumab to see how well it works compared to high-dose interferon alfa-2b in treating patients with high-risk stage I…